Table 4. Patients Achieving The LDL-C Goals Recommended By The Different Guidelines.
| NCEP ATP III/2004 NCEP ATP, n (%) | European/South African guidelines n (%) | |
| Overall survey | 1801 (60.5) | 1557 (52.3) |
| Age (years) | ||
| < 40 | 61 (42.4) | 52 (36.1) |
| 40–54 | 441 (56.0) | 382 (48.5) |
| 55–69 | 941 (62.4) | 822 (54.5) |
| ≥ 70 | 358 (66.8) | 301 (56.2) |
| Gender | ||
| Male | 992 (63.6) | 854 (54.7) |
| Female | 809 (57.1) | 706 (49.6) |
| Body mass index (kg/m2) | ||
| Normal weight (< 25 kg/m2) | 352 (61.6) | 293 (51.3) |
| Overweight (25–29 kg/m2) | 667 (61.7) | 584 (54.0) |
| Obese (≥ 30 kg/m2) | 780 (59.1) | 678 (51.4) |
| Coronary heart disease | 591 (56.0) | 532 (50.4) |
| Peripheral artery disease | 77 (52.7) | 69 (47.3) |
| Cerebrovascular atherosclerotic disease | 91 (58.7) | 81 (52.3) |
| Current smoker | 234 (52.9) | 213 (48.2) |
| Diabetes | 837 (59.6) | 764 (54.4) |
| Arterial hypertension | 1290 (60.6) | 1136 (53.4) |
| Family history of premature cardiovascular disease | 462 (53.5) | 391 (45.3) |
| Type of prevention | ||
| Primary prevention | 882 (67.0) | 722 (54.8) |
| Secondary prevention | 492 (56.9) | 437 (50.6) |
| Diabetes mellitus | 388 (58.2) | 364 (54.6) |
| Familial hypercholesterolaemia | 39 (30.2) | 34 (26.4) |
| Metabolic syndrome (Alberti et al. 2009) | 1177 (58.2) | 1031 (50.9) |
| Type of therapy | ||
| Statin monotherapy | 1720 (61.3) | 1485 (53.0) |
| Fibrates monotherapy | 9 (36.0) | 7 (28.0) |
| Combination therapy | 59 (48.8) | 53 (43.8) |
| Risk category | ||
| High risk | 1201 (55.5) | 1086 (50.2) |
| Medium/low risk | 600 (73.8) | 471 (57.9) |